Apreo Health
Private Company
Total funding raised: $3.2M
Overview
Apreo Health is a private, early-stage digital health company targeting the significant unmet needs in lung disease management. Operating in a pre-revenue, investigational stage, the company is developing a medical device platform currently limited to clinical investigations under U.S. regulatory law. Its mission centers on creating patient-centric, transformative solutions to improve respiratory health outcomes, positioning it in the high-growth digital therapeutics and remote monitoring landscape for chronic pulmonary conditions.
Technology Platform
Investigational digital health platform for lung disease, likely involving remote monitoring, digital biomarkers, and therapeutic software interventions.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
The digital health space for respiratory care is competitive, with numerous startups and established medtech companies developing connected inhalers, remote monitoring platforms, and digital therapeutics. Success will require demonstrating superior clinical outcomes, seamless integration, and clear economic value.